Immune Reconstitution Inflammatory Syndrome Occurring in a Kidney Transplant Patient with Extrapulmonary Tuberculosis
Open Access
- 7 March 2017
- journal article
- case report
- Published by Wiley in Case Reports in Transplantation
- Vol. 2017, 1-5
Abstract
Tuberculosis (TB) occurring in solid organ transplantation (SOT) is associated with significant morbidity and mortality usually due to delays in diagnosis, drug toxicity encountered with antimycobacterial therapy, and drug-drug interactions. TB in SOT patients may mimic other infectious and noninfectious posttransplant complications such as posttransplant lymphoproliferative disorder (PTLD) and systemic cytomegalovirus infection. Immune reconstitution inflammatory syndrome (IRIS) is a host response resulting in paradoxical worsening of an infectious disease which occurs after the employment of effective therapy and reversal of an immunosuppressed state. We describe the development of immune reconstitution inflammatory syndrome (IRIS), a unique complication occurring during the treatment of extrapulmonary tuberculosis occurring after transplant which resulted from decreasing immunosuppression in a patient who received Alemtuzumab induction therapy. Although (IRIS) has been originally described in HIV/AIDS patients receiving highly active antiretroviral therapy (HAART), solid organ transplant recipients with diagnosed or occult TB whose immune system may undergo immune reconstitution during their posttransplant course represent a new high risk group.Keywords
This publication has 26 references indexed in Scilit:
- Mycobacterium Tuberculosis—Associated Immune Reconstitution Syndrome in Solid-Organ Transplant RecipientsTransplantation, 2013
- Tuberculosis in a renal allograft recipient presenting with intussusceptionIndian Journal of Nephrology, 2012
- Drug interaction between rifampicin and sirolimus in transplant patients.2011
- Epidemiology of Extrapulmonary Tuberculosis in the United States, 1993–2006Clinical Infectious Diseases, 2009
- Tuberculosis in liver transplant recipients: A systematic review and meta-analysis of individual patient dataLiver Transplantation, 2009
- Tuberculosis in Solid‐Organ Transplant Recipients: Consensus Statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical MicrobiologyClinical Infectious Diseases, 2009
- Paradoxical worsening of tuberculosis in a heart–lung transplant recipientTransplant Infectious Disease, 2007
- Infectious Complications Associated with Alemtuzumab Use for Lymphoproliferative DisordersClinical Infectious Diseases, 2006
- Drug interaction between mycophenolate mofetil and rifampin: Possible induction of uridine diphosphate-glucuronosyltransferaseClinical Pharmacology & Therapeutics, 2005
- Mycobacterium tuberculosis Infection in Recipients of Solid Organ TransplantsClinical Infectious Diseases, 2005